Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | POLB | P06746 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | KLK7 | P49862 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7038724 | 0.91 | LMNA (0.40) | LMNAALDH1A1POLBSMN1; SMN2CRHR1 | |
| SCHEMBL6516178 | 0.74 | LMNA (0.44) | LMNAALDH1A1SMN1; SMN2KMT2AMAPK1 | |
| SCHEMBL6523981 | 0.72 | GAA (0.46) | LMNAALDH1A1POLBSMN1; SMN2KMT2A | |
| SCHEMBL6520891 | 0.69 | GAA (0.51) | LMNAALDH1A1POLBKMT2AMAPK1 | |
| SCHEMBL7040594 | 0.69 | PPARG (0.39) | LMNAGAA | |
| SCHEMBL6516656 | 0.68 | GAA (0.49) | LMNAALDH1A1POLBKMT2AMAPK1 | |
| SCHEMBL6516174 | 0.67 | LMNA (0.48) | LMNAALDH1A1POLBSMN1; SMN2KMT2A | |
| SCHEMBL7042226 | 0.67 | PKM (0.36) | ALDH1A1POLB | |
| SCHEMBL28969236 | 0.67 | LMNA (0.54) | LMNAALDH1A1POLBSMN1; SMN2KMT2A | |
| SCHEMBL410350 | 0.67 | LMNA (0.67) | LMNAALDH1A1POLBSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | LMNA 2459/4885ALDH1A1 1254/4885POLB 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.